Revenue: The sum of all revenue fields included for a company's operating activities.
Caribou Biosciences, Inc. (CRBU) had Revenue of $9.99M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
|
Revenue |
$9.99M |
$-149.10M |
|
-- |
|
$9.99M |
|
$176.61M |
|
$-166.62M |
|
$17.50M |
|
$-149.11M |
|
$-149.11M |
|
$-149.10M |
|
$-149.10M |
|
$-149.10M |
|
$-149.10M |
|
$-166.62M |
|
$-167.41M |
|
90.32M |
|
90.32M |
|
$-1.65 |
|
$-1.65 |
|
| Balance Sheet Financials | |
$219.38M |
|
$19.28M |
|
$93.94M |
|
$313.31M |
|
$30.65M |
|
-- |
|
$29.71M |
|
$60.36M |
|
$252.95M |
|
$252.95M |
|
$252.95M |
|
92.38M |
|
| Cash Flow Statement Financials | |
$-138.20M |
|
$86.61M |
|
$16.72M |
|
$51.21M |
|
$16.34M |
|
$-34.87M |
|
$16.71M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
7.16 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-1667.16% |
|
-1667.16% |
|
-1675.15% |
|
-1492.04% |
|
-1491.94% |
|
$-143.07M |
|
-- |
|
-- |
|
-- |
|
0.03 |
|
-- |
|
4.78 |
|
76.44 |
|
-58.95% |
|
-58.95% |
|
-47.59% |
|
-58.95% |
|
$2.74 |
|
$-1.58 |
|
$-1.53 |
|